Prognosis of Atrial Fibrillation with or without Comorbidities: Analysis of Younger Adults from a Nationwide Database.
atrial fibrillation
comorbidities
heart disease
heart failure
mortality
prognosis
stroke
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
01 Apr 2022
01 Apr 2022
Historique:
received:
09
03
2022
revised:
21
03
2022
accepted:
26
03
2022
entrez:
12
4
2022
pubmed:
13
4
2022
medline:
13
4
2022
Statut:
epublish
Résumé
Objective: To assess the prognosis of AF patients with or without cardiac or extra-cardiac concomitant conditions. Participants and Methods: All consecutive patients diagnosed with AF admitted to French hospitals between 2011 and 2020 were identified. Patients were classified into four groups: (1) > 60 yo; (2) with known cardiac disease (KCD group); (3) with extra-cardiac comorbidities (ECC); and 4) AF without KCD or ECC (“Lone AF”). Results: Altogether 2,435,541 patients were identified, from which 2,203,702 patients aged >60 years and 231,839 patients aged <60 years (with KCD (55.2%), with ECC (14.7%) and with “Lone AF” (30.1%)). During follow-up, the incidences of all-cause and CV deaths were 13.7%, 5.7%, 6.2%, and 2.3%, and 4.2%, 1.7%, 0.8%, and 0.3% in the older than 60 yo group, KCD group, ECC group and “Lone AF” AF group, respectively. In the age and sex-adjusted analysis (patients < 60 yo), patients with AF and KCD had worse outcomes than patients with “Lone AF” for all major cardiac events. Conclusion: There are three distinct prognostic criteria based on the presence or lack of HD or extra-cardiac concomitant comorbidities. Patients in the so-called “Lone AF” group remain severe in terms of CV events but still with a lower incidence than the patients with associated KCD or ECC. The presence of KCD or ECC makes it possible to distinguish a profile in terms of events that are very different between the patients.
Identifiants
pubmed: 35407589
pii: jcm11071981
doi: 10.3390/jcm11071981
pmc: PMC8999868
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Am J Cardiol. 2020 Sep 15;131:127-128
pubmed: 32709421
Mayo Clin Proc. 2019 Dec;94(12):2427-2436
pubmed: 31668449
Europace. 2018 Nov 1;20(11):1750-1757
pubmed: 29518195
Eur Heart J. 2006 Feb;27(3):357-64
pubmed: 16275661
JAMA Netw Open. 2021 Dec 1;4(12):e2140071
pubmed: 34932104
Br Heart J. 1954 Apr;16(2):189-94
pubmed: 13160271
Europace. 2013 Jan;15(1):18-23
pubmed: 22782972
N Engl J Med. 1998 Sep 3;339(10):659-66
pubmed: 9725923
Circulation. 2004 Aug 31;110(9):1042-6
pubmed: 15313941
Europace. 2012 Feb;14(2):184-90
pubmed: 22135317
Am Heart J. 2017 Mar;185:74-84
pubmed: 28267478
Circ Res. 1977 Jul;41(1):9-18
pubmed: 862147
Stud Health Technol Inform. 2015;210:419-23
pubmed: 25991178
Circulation. 2007 Jun 19;115(24):3050-6
pubmed: 17548732
J Am Coll Cardiol. 2003 Jun 18;41(12):2185-92
pubmed: 12821245
Europace. 2018 Jun 1;20(6):921-928
pubmed: 28541417
BMC Med. 2021 Oct 20;19(1):256
pubmed: 34666757
Arch Intern Med. 2004 Oct 11;164(18):1993-8
pubmed: 15477433
Eur Heart J. 1999 Jun;20(12):896-9
pubmed: 10329095
Nat Rev Cardiol. 2017 Nov;14(11):627-628
pubmed: 28960189
Thromb Haemost. 2022 Mar;122(3):406-414
pubmed: 34020488
J Am Coll Cardiol. 2014 May 6;63(17):1715-23
pubmed: 24530673
Eur Heart J. 2021 Feb 1;42(5):373-498
pubmed: 32860505
Stroke. 2015 Sep;46(9):2432-7
pubmed: 26251249
J Clin Med. 2020 Apr 24;9(4):
pubmed: 32344603
Int J Cardiol. 2018 Mar 15;255:74-79
pubmed: 29174184
Chest. 2012 Feb;141(2):339-347
pubmed: 21622553
J Clin Epidemiol. 2011 Sep;64(9):1014-22
pubmed: 21330103
Europace. 2020 Jun 1;22(6):870-877
pubmed: 32215649
Eur Heart J. 2005 Dec;26(23):2556-61
pubmed: 16141257
J Am Coll Cardiol. 2017 Apr 18;69(15):1968-1982
pubmed: 28408027